APO Research

APO RESEARCH · REPORT

Mydriatic Eyedrops

Selected research

Industry Growth & Trends

Global Mydriatic Eyedrops Industry Growth and Trends Forecast to 2032

Market perspective

The global Mydriatic Eyedrops market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mydriatic Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mydriatic Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mydriatic Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mydriatic Eyedrops include Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon and Viva Opti-Free, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mydriatic Eyedrops market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mydriatic Eyedrops market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mydriatic Eyedrops market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mydriatic Eyedrops.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mydriatic Eyedrops market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mydriatic Eyedrops Market by Company

Novartis AG

Allergan, Inc.

Meda Pharmaceuticals Inc

Bausch & Lomb Inc

Cigna

Similasan Corporation

Visine

Alcon

Viva Opti-Free

Bausch & Lomb

Systane

Rite Aid

Walgreens

Staples

Clear eyes

Mydriatic Eyedrops Segment by Type

Atropine

Homatropine

Dolly

Others

Mydriatic Eyedrops Segment by Application

Adult

Children

Mydriatic Eyedrops Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mydriatic Eyedrops market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mydriatic Eyedrops and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mydriatic Eyedrops.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mydriatic Eyedrops manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mydriatic Eyedrops in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Atropine Table 2. Major Company of Homatropine Table 3. Major Company of Dolly Table 4. Major Company of Others Table 5. Global Mydriatic Eyedrops Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Mydriatic Eyedrops Sales by Type (2021-2026) & (W Units) Table 7. Global Mydriatic Eyedrops Sales Market Share in Volume by Type (2021-2026) Table 8. Global Mydriatic Eyedrops Sales by Type (2021-2026) & (US$ Million) Table 9. Global Mydriatic Eyedrops Sales Market Share in Value by Type (2021-2026) Table 10. Global Mydriatic Eyedrops Price by Type (2021-2026) & (US$/Unit) Table 11. Global Mydriatic Eyedrops Sales by Type (2027-2032) & (W Units) Table 12. Global Mydriatic Eyedrops Sales Market Share in Volume by Type (2027-2032) Table 13. Global Mydriatic Eyedrops Sales by Type (2027-2032) & (US$ Million) Table 14. Global Mydriatic Eyedrops Sales Market Share in Value by Type (2027-2032) Table 15. Global Mydriatic Eyedrops Price by Type (2027-2032) & (US$/Unit) Table 16. North America Mydriatic Eyedrops Sales by Type (2021-2026) & (W Units) Table 17. North America Mydriatic Eyedrops Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Mydriatic Eyedrops Sales by Type (2021-2026) & (W Units) Table 19. Europe Mydriatic Eyedrops Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Mydriatic Eyedrops Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Mydriatic Eyedrops Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Mydriatic Eyedrops Sales by Type (2021-2026) & (W Units) Table 23. Latin America Mydriatic Eyedrops Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Mydriatic Eyedrops Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Mydriatic Eyedrops Sales by Type (2021-2026) & (US$ Million) Table 26. Mydriatic Eyedrops Industry Trends Table 27. Mydriatic Eyedrops Industry Drivers Table 28. Mydriatic Eyedrops Industry Opportunities and Challenges Table 29. Mydriatic Eyedrops Industry Restraints Table 30. Global Mydriatic Eyedrops Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Mydriatic Eyedrops Revenue Market Share by Company (2021-2026) Table 32. Global Mydriatic Eyedrops Sales by Company (2021-2026) & (W Units) Table 33. Global Mydriatic Eyedrops Sales Share by Company (2021-2026) Table 34. Global Mydriatic Eyedrops Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Mydriatic Eyedrops Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Mydriatic Eyedrops Major Company Production Sites and Headquarters Table 37. Global Mydriatic Eyedrops Company, Product Type & Application Table 38. Global Mydriatic Eyedrops Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Mydriatic Eyedrops by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Mydriatic Eyedrops Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Mydriatic Eyedrops Sales by Region (2021-2026) & (W Units) Table 43. Global Mydriatic Eyedrops Sales Market Share in Volume by Region (2021-2026) Table 44. Global Mydriatic Eyedrops Sales by Region (2021-2026) & (US$ Million) Table 45. Global Mydriatic Eyedrops Sales Market Share in Value by Region (2021-2026) Table 46. Global Mydriatic Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Mydriatic Eyedrops Sales by Region (2027-2032) & (W Units) Table 48. Global Mydriatic Eyedrops Sales Market Share in Volume by Region (2027-2032) Table 49. Global Mydriatic Eyedrops Sales by Region (2027-2032) & (US$ Million) Table 50. Global Mydriatic Eyedrops Sales Market Share in Value by Region (2027-2032) Table 51. Global Mydriatic Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Mydriatic Eyedrops Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Mydriatic Eyedrops Sales by Application (2021-2026) & (W Units) Table 54. Global Mydriatic Eyedrops Sales Market Share in Volume by Application (2021-2026) Table 55. Global Mydriatic Eyedrops Sales by Application (2021-2026) & (US$ Million) Table 56. Global Mydriatic Eyedrops Sales Market Share in Value by Application (2021-2026) Table 57. Global Mydriatic Eyedrops Price by Application (2021-2026) & (US$/Unit) Table 58. Global Mydriatic Eyedrops Sales by Application (2027-2032) & (W Units) Table 59. Global Mydriatic Eyedrops Sales Market Share in Volume by Application (2027-2032) Table 60. Global Mydriatic Eyedrops Sales by Application (2027-2032) & (US$ Million) Table 61. Global Mydriatic Eyedrops Sales Market Share in Value by Application (2027-2032) Table 62. Global Mydriatic Eyedrops Price by Application (2027-2032) & (US$/Unit) Table 63. North America Mydriatic Eyedrops Sales by Application (2021-2026) & (W Units) Table 64. North America Mydriatic Eyedrops Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Mydriatic Eyedrops Sales by Application (2021-2026) & (W Units) Table 66. Europe Mydriatic Eyedrops Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Mydriatic Eyedrops Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Mydriatic Eyedrops Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Mydriatic Eyedrops Sales by Application (2021-2026) & (W Units) Table 70. Latin America Mydriatic Eyedrops Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Mydriatic Eyedrops Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Mydriatic Eyedrops Sales by Application (2021-2026) & (US$ Million) Table 73. Novartis AG Company Information Table 74. Novartis AG Business Overview Table 75. Novartis AG Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Novartis AG Mydriatic Eyedrops Product Portfolio Table 77. Novartis AG Recent Development Table 78. Allergan, Inc. Company Information Table 79. Allergan, Inc. Business Overview Table 80. Allergan, Inc. Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Allergan, Inc. Mydriatic Eyedrops Product Portfolio Table 82. Allergan, Inc. Recent Development Table 83. Meda Pharmaceuticals Inc Company Information Table 84. Meda Pharmaceuticals Inc Business Overview Table 85. Meda Pharmaceuticals Inc Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Meda Pharmaceuticals Inc Mydriatic Eyedrops Product Portfolio Table 87. Meda Pharmaceuticals Inc Recent Development Table 88. Bausch & Lomb Inc Company Information Table 89. Bausch & Lomb Inc Business Overview Table 90. Bausch & Lomb Inc Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Bausch & Lomb Inc Mydriatic Eyedrops Product Portfolio Table 92. Bausch & Lomb Inc Recent Development Table 93. Cigna Company Information Table 94. Cigna Business Overview Table 95. Cigna Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Cigna Mydriatic Eyedrops Product Portfolio Table 97. Cigna Recent Development Table 98. Similasan Corporation Company Information Table 99. Similasan Corporation Business Overview Table 100. Similasan Corporation Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Similasan Corporation Mydriatic Eyedrops Product Portfolio Table 102. Similasan Corporation Recent Development Table 103. Visine Company Information Table 104. Visine Business Overview Table 105. Visine Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Visine Mydriatic Eyedrops Product Portfolio Table 107. Visine Recent Development Table 108. Alcon Company Information Table 109. Alcon Business Overview Table 110. Alcon Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Alcon Mydriatic Eyedrops Product Portfolio Table 112. Alcon Recent Development Table 113. Viva Opti-Free Company Information Table 114. Viva Opti-Free Business Overview Table 115. Viva Opti-Free Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Viva Opti-Free Mydriatic Eyedrops Product Portfolio Table 117. Viva Opti-Free Recent Development Table 118. Bausch & Lomb Company Information Table 119. Bausch & Lomb Business Overview Table 120. Bausch & Lomb Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Bausch & Lomb Mydriatic Eyedrops Product Portfolio Table 122. Bausch & Lomb Recent Development Table 123. Systane Company Information Table 124. Systane Business Overview Table 125. Systane Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Systane Mydriatic Eyedrops Product Portfolio Table 127. Systane Recent Development Table 128. Rite Aid Company Information Table 129. Rite Aid Business Overview Table 130. Rite Aid Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Rite Aid Mydriatic Eyedrops Product Portfolio Table 132. Rite Aid Recent Development Table 133. Walgreens Company Information Table 134. Walgreens Business Overview Table 135. Walgreens Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Walgreens Mydriatic Eyedrops Product Portfolio Table 137. Walgreens Recent Development Table 138. Staples Company Information Table 139. Staples Business Overview Table 140. Staples Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Staples Mydriatic Eyedrops Product Portfolio Table 142. Staples Recent Development Table 143. Clear eyes Company Information Table 144. Clear eyes Business Overview Table 145. Clear eyes Mydriatic Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Clear eyes Mydriatic Eyedrops Product Portfolio Table 147. Clear eyes Recent Development Table 148. North America Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 149. North America Mydriatic Eyedrops Sales by Country (2021-2026) & (W Units) Table 150. North America Mydriatic Eyedrops Sales Market Share by Country (2021-2026) Table 151. North America Mydriatic Eyedrops Sales Forecast by Country (2027-2032) & (W Units) Table 152. North America Mydriatic Eyedrops Sales Market Share Forecast by Country (2027-2032) Table 153. North America Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Mydriatic Eyedrops Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Mydriatic Eyedrops Market Share by Country (2021-2026) Table 156. North America Mydriatic Eyedrops Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Mydriatic Eyedrops Market Share Forecast by Country (2027-2032) Table 158. Europe Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 159. Europe Mydriatic Eyedrops Sales by Country (2021-2026) & (W Units) Table 160. Europe Mydriatic Eyedrops Sales Market Share by Country (2021-2026) Table 161. Europe Mydriatic Eyedrops Sales Forecast by Country (2027-2032) & (W Units) Table 162. Europe Mydriatic Eyedrops Sales Market Share Forecast by Country (2027-2032) Table 163. Europe Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Europe Mydriatic Eyedrops Market Size by Country (2021-2026) & (US$ Million) Table 165. Europe Mydriatic Eyedrops Market Share by Country (2021-2026) Table 166. Europe Mydriatic Eyedrops Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Europe Mydriatic Eyedrops Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Mydriatic Eyedrops Sales by Country (2021-2026) & (W Units) Table 170. Asia-Pacific Mydriatic Eyedrops Sales Market Share by Country (2021-2026) Table 171. Asia-Pacific Mydriatic Eyedrops Sales Forecast by Country (2027-2032) & (W Units) Table 172. Asia-Pacific Mydriatic Eyedrops Sales Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Mydriatic Eyedrops Market Size by Country (2021-2026) & (US$ Million) Table 175. Asia-Pacific Mydriatic Eyedrops Market Share by Country (2021-2026) Table 176. Asia-Pacific Mydriatic Eyedrops Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Asia-Pacific Mydriatic Eyedrops Market Share Forecast by Country (2027-2032) Table 178. Latin America Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 179. Latin America Mydriatic Eyedrops Sales by Country (2021-2026) & (W Units) Table 180. Latin America Mydriatic Eyedrops Sales Market Share by Country (2021-2026) Table 181. Latin America Mydriatic Eyedrops Sales Forecast by Country (2027-2032) & (W Units) Table 182. Latin America Mydriatic Eyedrops Sales Market Share Forecast by Country (2027-2032) Table 183. Latin America Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Latin America Mydriatic Eyedrops Market Size by Country (2021-2026) & (US$ Million) Table 185. Latin America Mydriatic Eyedrops Market Share by Country (2021-2026) Table 186. Latin America Mydriatic Eyedrops Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Latin America Mydriatic Eyedrops Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Mydriatic Eyedrops Sales by Country (2021-2026) & (W Units) Table 190. Middle East and Africa Mydriatic Eyedrops Sales Market Share by Country (2021-2026) Table 191. Middle East and Africa Mydriatic Eyedrops Sales Forecast by Country (2027-2032) & (W Units) Table 192. Middle East and Africa Mydriatic Eyedrops Sales Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Mydriatic Eyedrops Market Size by Country (2021-2026) & (US$ Million) Table 195. Middle East and Africa Mydriatic Eyedrops Market Share by Country (2021-2026) Table 196. Middle East and Africa Mydriatic Eyedrops Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Middle East and Africa Mydriatic Eyedrops Market Share Forecast by Country (2027-2032) Table 198. Key Raw Materials Table 199. Raw Materials Key Suppliers Table 200. Mydriatic Eyedrops Distributors List Table 201. Mydriatic Eyedrops Customers List Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. Mydriatic Eyedrops Image Figure 2. Global Mydriatic Eyedrops Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mydriatic Eyedrops Market Size (2021-2032) & (US$ Million) Figure 4. Global Mydriatic Eyedrops Sales (2021-2032) & (W Units) Figure 5. Atropine Image Figure 6. Global Atropine Sales YoY Growth (2021-2032) & (W Units) Figure 7. Homatropine Image Figure 8. Global Homatropine Sales YoY Growth (2021-2032) & (W Units) Figure 9. Dolly Image Figure 10. Global Dolly Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Mydriatic Eyedrops Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Mydriatic Eyedrops Market Share by Type 2025 VS 2032 Figure 15. North America Mydriatic Eyedrops Sales Market Share in Volume by Type in 2025 Figure 16. North America Mydriatic Eyedrops Sales Market Share in Value by Type in 2025 Figure 17. Europe Mydriatic Eyedrops Sales Market Share in Volume by Type in 2025 Figure 18. Europe Mydriatic Eyedrops Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Mydriatic Eyedrops Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Mydriatic Eyedrops Sales Market Share in Value by Type in 2025 Figure 21. Latin America Mydriatic Eyedrops Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Mydriatic Eyedrops Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Mydriatic Eyedrops Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Mydriatic Eyedrops Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Mydriatic Eyedrops Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Adult Image Figure 28. Global Adult Sales YoY Growth (2021-2032) & (W Units) Figure 29. Children Image Figure 30. Global Children Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Mydriatic Eyedrops Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Mydriatic Eyedrops Market Share by Application 2025 VS 2032 Figure 33. North America Mydriatic Eyedrops Sales Market Share in Volume by Application in 2025 Figure 34. North America Mydriatic Eyedrops Sales Market Share in Value by Application in 2025 Figure 35. Europe Mydriatic Eyedrops Sales Market Share in Volume by Application in 2025 Figure 36. Europe Mydriatic Eyedrops Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Mydriatic Eyedrops Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Mydriatic Eyedrops Sales Market Share in Value by Application in 2025 Figure 39. Latin America Mydriatic Eyedrops Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Mydriatic Eyedrops Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Mydriatic Eyedrops Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Mydriatic Eyedrops Sales Market Share in Value by Application in 2025 Figure 43. North America Mydriatic Eyedrops Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Mydriatic Eyedrops Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Mydriatic Eyedrops Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Mydriatic Eyedrops Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Mydriatic Eyedrops Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Mydriatic Eyedrops Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Mydriatic Eyedrops Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Mydriatic Eyedrops Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Mydriatic Eyedrops Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Mydriatic Eyedrops Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Mydriatic Eyedrops Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Mydriatic Eyedrops Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Mydriatic Eyedrops Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Mydriatic Eyedrops Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Mydriatic Eyedrops Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Mydriatic Eyedrops Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Mydriatic Eyedrops Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Mydriatic Eyedrops Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Mydriatic Eyedrops Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Mydriatic Eyedrops Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Mydriatic Eyedrops Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Mydriatic Eyedrops Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Atropine
  • Homatropine
  • Dolly
  • Others
Applications
  • Adult
  • Children
Companies covered
  • Novartis AG
  • Allergan, Inc.
  • Meda Pharmaceuticals Inc
  • Bausch & Lomb Inc
  • Cigna
  • Similasan Corporation
  • Visine
  • Alcon
  • Viva Opti-Free
  • Bausch & Lomb
  • Systane
  • Rite Aid
  • Walgreens
  • Staples
  • Clear eyes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mydriatic Eyedrops Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mydriatic Eyedrops Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mydriatic Eyedrops Market by Type
  6. 1.3.1 Atropine
  7. 1.3.2 Homatropine
  8. 1.3.3 Dolly
  9. 1.3.4 Others
  10. 1.4 Global Mydriatic Eyedrops Market Size by Type
  11. 1.4.1 Global Mydriatic Eyedrops Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Mydriatic Eyedrops Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Mydriatic Eyedrops Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Mydriatic Eyedrops Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Mydriatic Eyedrops Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Mydriatic Eyedrops Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Mydriatic Eyedrops Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Mydriatic Eyedrops Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mydriatic Eyedrops Industry Trends
  2. 2.2 Mydriatic Eyedrops Industry Drivers
  3. 2.3 Mydriatic Eyedrops Industry Opportunities and Challenges
  4. 2.4 Mydriatic Eyedrops Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mydriatic Eyedrops Revenue (2021-2026)
  2. 3.2 Global Top Players by Mydriatic Eyedrops Sales (2021-2026)
  3. 3.3 Global Top Players by Mydriatic Eyedrops Price (2021-2026)
  4. 3.4 Global Mydriatic Eyedrops Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mydriatic Eyedrops Major Company Production Sites & Headquarters
  6. 3.6 Global Mydriatic Eyedrops Company, Product Type & Application
  7. 3.7 Global Mydriatic Eyedrops Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mydriatic Eyedrops Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mydriatic Eyedrops Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mydriatic Eyedrops Tier 1, Tier 2, and Tier 3
4 Mydriatic Eyedrops Regional Status and Outlook
  1. 4.1 Global Mydriatic Eyedrops Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mydriatic Eyedrops Historic Market Size by Region
  3. 4.2.1 Global Mydriatic Eyedrops Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mydriatic Eyedrops Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mydriatic Eyedrops Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mydriatic Eyedrops Forecasted Market Size by Region
  7. 4.3.1 Global Mydriatic Eyedrops Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mydriatic Eyedrops Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mydriatic Eyedrops Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mydriatic Eyedrops by Application
  1. 5.1 Mydriatic Eyedrops Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global Mydriatic Eyedrops Market Size by Application
  5. 5.2.1 Global Mydriatic Eyedrops Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Mydriatic Eyedrops Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Mydriatic Eyedrops Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Mydriatic Eyedrops Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Mydriatic Eyedrops Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Mydriatic Eyedrops Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Mydriatic Eyedrops Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Mydriatic Eyedrops Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Mydriatic Eyedrops Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Allergan, Inc.
  8. 6.2.1 Allergan, Inc. Company Information
  9. 6.2.2 Allergan, Inc. Business Overview
  10. 6.2.3 Allergan, Inc. Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Allergan, Inc. Mydriatic Eyedrops Product Portfolio
  12. 6.2.5 Allergan, Inc. Recent Developments
  13. 6.3 Meda Pharmaceuticals Inc
  14. 6.3.1 Meda Pharmaceuticals Inc Company Information
  15. 6.3.2 Meda Pharmaceuticals Inc Business Overview
  16. 6.3.3 Meda Pharmaceuticals Inc Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Meda Pharmaceuticals Inc Mydriatic Eyedrops Product Portfolio
  18. 6.3.5 Meda Pharmaceuticals Inc Recent Developments
  19. 6.4 Bausch & Lomb Inc
  20. 6.4.1 Bausch & Lomb Inc Company Information
  21. 6.4.2 Bausch & Lomb Inc Business Overview
  22. 6.4.3 Bausch & Lomb Inc Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bausch & Lomb Inc Mydriatic Eyedrops Product Portfolio
  24. 6.4.5 Bausch & Lomb Inc Recent Developments
  25. 6.5 Cigna
  26. 6.5.1 Cigna Company Information
  27. 6.5.2 Cigna Business Overview
  28. 6.5.3 Cigna Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cigna Mydriatic Eyedrops Product Portfolio
  30. 6.5.5 Cigna Recent Developments
  31. 6.6 Similasan Corporation
  32. 6.6.1 Similasan Corporation Company Information
  33. 6.6.2 Similasan Corporation Business Overview
  34. 6.6.3 Similasan Corporation Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Similasan Corporation Mydriatic Eyedrops Product Portfolio
  36. 6.6.5 Similasan Corporation Recent Developments
  37. 6.7 Visine
  38. 6.7.1 Visine Company Information
  39. 6.7.2 Visine Business Overview
  40. 6.7.3 Visine Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Visine Mydriatic Eyedrops Product Portfolio
  42. 6.7.5 Visine Recent Developments
  43. 6.8 Alcon
  44. 6.8.1 Alcon Company Information
  45. 6.8.2 Alcon Business Overview
  46. 6.8.3 Alcon Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Alcon Mydriatic Eyedrops Product Portfolio
  48. 6.8.5 Alcon Recent Developments
  49. 6.9 Viva Opti-Free
  50. 6.9.1 Viva Opti-Free Company Information
  51. 6.9.2 Viva Opti-Free Business Overview
  52. 6.9.3 Viva Opti-Free Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Viva Opti-Free Mydriatic Eyedrops Product Portfolio
  54. 6.9.5 Viva Opti-Free Recent Developments
  55. 6.10 Bausch & Lomb
  56. 6.10.1 Bausch & Lomb Company Information
  57. 6.10.2 Bausch & Lomb Business Overview
  58. 6.10.3 Bausch & Lomb Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bausch & Lomb Mydriatic Eyedrops Product Portfolio
  60. 6.10.5 Bausch & Lomb Recent Developments
  61. 6.11 Systane
  62. 6.11.1 Systane Company Information
  63. 6.11.2 Systane Business Overview
  64. 6.11.3 Systane Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Systane Mydriatic Eyedrops Product Portfolio
  66. 6.11.5 Systane Recent Developments
  67. 6.12 Rite Aid
  68. 6.12.1 Rite Aid Company Information
  69. 6.12.2 Rite Aid Business Overview
  70. 6.12.3 Rite Aid Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Rite Aid Mydriatic Eyedrops Product Portfolio
  72. 6.12.5 Rite Aid Recent Developments
  73. 6.13 Walgreens
  74. 6.13.1 Walgreens Company Information
  75. 6.13.2 Walgreens Business Overview
  76. 6.13.3 Walgreens Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Walgreens Mydriatic Eyedrops Product Portfolio
  78. 6.13.5 Walgreens Recent Developments
  79. 6.14 Staples
  80. 6.14.1 Staples Company Information
  81. 6.14.2 Staples Business Overview
  82. 6.14.3 Staples Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Staples Mydriatic Eyedrops Product Portfolio
  84. 6.14.5 Staples Recent Developments
  85. 6.15 Clear eyes
  86. 6.15.1 Clear eyes Company Information
  87. 6.15.2 Clear eyes Business Overview
  88. 6.15.3 Clear eyes Mydriatic Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Clear eyes Mydriatic Eyedrops Product Portfolio
  90. 6.15.5 Clear eyes Recent Developments
7 North America by Country
  1. 7.1 North America Mydriatic Eyedrops Sales by Country
  2. 7.1.1 North America Mydriatic Eyedrops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mydriatic Eyedrops Sales by Country (2021-2026)
  4. 7.1.3 North America Mydriatic Eyedrops Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mydriatic Eyedrops Market Size by Country
  6. 7.2.1 North America Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mydriatic Eyedrops Market Size by Country (2021-2026)
  8. 7.2.3 North America Mydriatic Eyedrops Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mydriatic Eyedrops Sales by Country
  2. 8.1.1 Europe Mydriatic Eyedrops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mydriatic Eyedrops Sales by Country (2021-2026)
  4. 8.1.3 Europe Mydriatic Eyedrops Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mydriatic Eyedrops Market Size by Country
  6. 8.2.1 Europe Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mydriatic Eyedrops Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mydriatic Eyedrops Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mydriatic Eyedrops Sales by Country
  2. 9.1.1 Asia-Pacific Mydriatic Eyedrops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mydriatic Eyedrops Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mydriatic Eyedrops Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mydriatic Eyedrops Market Size by Country
  6. 9.2.1 Asia-Pacific Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mydriatic Eyedrops Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mydriatic Eyedrops Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mydriatic Eyedrops Sales by Country
  2. 10.1.1 South America Mydriatic Eyedrops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mydriatic Eyedrops Sales by Country (2021-2026)
  4. 10.1.3 South America Mydriatic Eyedrops Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mydriatic Eyedrops Market Size by Country
  6. 10.2.1 South America Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mydriatic Eyedrops Market Size by Country (2021-2026)
  8. 10.2.3 South America Mydriatic Eyedrops Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mydriatic Eyedrops Sales by Country
  2. 11.1.1 Middle East and Africa Mydriatic Eyedrops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mydriatic Eyedrops Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mydriatic Eyedrops Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mydriatic Eyedrops Market Size by Country
  6. 11.2.1 Middle East and Africa Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mydriatic Eyedrops Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mydriatic Eyedrops Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mydriatic Eyedrops Value Chain Analysis
  2. 12.1.1 Mydriatic Eyedrops Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mydriatic Eyedrops Production Mode & Process
  7. 12.2 Mydriatic Eyedrops Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mydriatic Eyedrops Distributors
  10. 12.2.3 Mydriatic Eyedrops Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research